3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Breast Neoplasms
5
Papillomavirus Infections
4
Uterine Cervical Neoplasms
3
Uterine Cervical Dysplasia
3
Pancreatic Neoplasms
3
Neoplasms
3
Multiple Myeloma
3
Lymphoma, Follicular
3
Triple Negative Breast Neoplasms
2
Lymphoma, Mantle-Cell
2
Lymphoma
2
Lung Neoplasms
2
Waldenstrom Macroglobulinemia
1
Thymic aplasia
1
Squamous Cell Carcinoma of Head and Neck
1
Prostatic Neoplasms
1
Pneumonia
1
Osteosarcoma
1
Obesity
1
Neurofibromatosis 1
1
Neuroblastoma
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphohistiocytosis, Hemophagocytic
1
Interventions
Gemcitabine
31
Cisplatin
21
pembrolizumab
8
Fluorouracil
6
Oxaliplatin
5
Capecitabine
5
130-nm albumin-bound paclitaxel
5
durvalumab
4
Taxes
4
Albumin-Bound Paclitaxel
4
pemigatinib
3
infigratinib
3
atezolizumab
3
Specimen Handling
3
Radiosurgery
3
Platinum
3
Magnetic Resonance Spectroscopy
3
Leucovorin
3
Carboplatin
3
Biopsy
3
1,2-diaminocyclohexaneplatinum II citrate
3
tremelimumab
2
trametinib
2
olaparib
2
ivosidenib
2
derazantinib
2
cobimetinib
2
Trastuzumab
2
Radiotherapy
2
Panitumumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Cholangiocarcinoma
×
Blood Specimen Collection
×
Clear all
No trials found.